Risk Factors Update Summary
- Net losses increased significantly from $248.7 million to $436.4 million in 2022.
- Adverse events in the financial services industry may lead to liquidity problems, impacting our business.
- Increased full-time employees from 246 to 378, including 202 in research and development.
- Accumulated deficit rose from $701 million to $1,137 million as of December 31, 2023.
- Cash exceeding FDIC limits held in banking institutions poses risk of loss if institutions fail.
- Dilution to stockholders due to substantial issuance of common stock in the EQRx Acquisition.
- Cash, cash equivalents, and marketable securities increased from $644 million to $1,853 million.
- Completed EQRx Acquisition resulted in substantial dilution to stockholders.
- Potential legislation restricting collaboration with Chinese biotech companies could impact operations.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1628171&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.